N-[[(5-methyl-3-phenylisoxazol-4-yl)-phenyl]sulfonyl]propanamide, sodium salt, parecoxib sodium: A potent and selective inhibitor of COX-2 for parenteral administration.
Searle Research and Development, 700 Chesterfield Parkway, St. Louis, Missouri 63198, and 4901 Searle Parkway, Skokie, Illinois 60077, USA. john.j.talley@monstanto.com